Phibro Animal Health Corporation Company Profile (NASDAQ:PAHC)

About Phibro Animal Health Corporation (NASDAQ:PAHC)

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products. The Company also manufactures and markets specific ingredients for use in the personal care, automotive, industrial chemical and chemical catalyst industries. The Company's Medicated Feed Additives (MFAs) and other business consist of concentrated medicated products, which are administered through animal feeds. The Company's MFAs and other business consists of the production and sale of antibacterials, including Stafac, Terramycin, Neo-Terramycin and Mecadox and anticoccidials, including Nicarb, Aviax, Aviax Plus, Coxistac and amprolium.

Industry, Sector and Symbol:

Sector: Medical
Industry: Veterinary Drugs
Sub-Industry: N/A
Symbol: NASDAQ:PAHC
CUSIP: N/A
Web: www.pahc.com

Capitalization:

Market Cap: $1.50773 billion
Outstanding Shares: 19,556,000

Average Prices:

50 Day Moving Avg: $36.49
200 Day Moving Avg: $35.16
52 Week Range: $24.83 - $40.25

P/E:

Trailing P/E Ratio: 23.26
Foreward P/E Ratio: 22.29
P/E Growth: 5.17

Sales & Book Value:

Annual Revenue: $764.28 million
Price / Sales: 0.96
Book Value: $3.79 per share
Price / Book: 9.88

Dividend:

Annual Dividend: $0.40
Dividend Yield: 1.1%

Profitability:

EBITDA: $117.92 million
Net Margins: 8.45%
Return on Equity: 47.88%
Return on Assets: 10.02%

Debt:

Debt-to-Equity Ratio: 2.03%
Current Ratio: 3.14%
Quick Ratio: 1.75%

Misc:

Average Volume: 135,575 shs.
Beta: 1.36
Short Ratio: 1.56

Frequently Asked Questions for Phibro Animal Health Corporation (NASDAQ:PAHC)

What is Phibro Animal Health Corporation's stock symbol?

Phibro Animal Health Corporation trades on the NASDAQ under the ticker symbol "PAHC."

How often does Phibro Animal Health Corporation pay dividends? What is the dividend yield for Phibro Animal Health Corporation?

Phibro Animal Health Corporation announced a quarterly dividend on Tuesday, July 25th. Investors of record on Wednesday, September 6th will be paid a dividend of $0.10 per share on Wednesday, September 27th. This represents a $0.40 dividend on an annualized basis and a yield of 1.07%. The ex-dividend date of this dividend is Friday, September 1st. View Phibro Animal Health Corporation's Dividend History.

How were Phibro Animal Health Corporation's earnings last quarter?

Phibro Animal Health Corporation (NASDAQ:PAHC) issued its quarterly earnings results on Wednesday, August, 30th. The company reported $0.39 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.35 by $0.04. The firm earned $194.84 million during the quarter, compared to the consensus estimate of $192.47 million. Phibro Animal Health Corporation had a net margin of 8.45% and a return on equity of 47.88%. The business's revenue was up 3.0% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.32 EPS. View Phibro Animal Health Corporation's Earnings History.

When will Phibro Animal Health Corporation make its next earnings announcement?

Phibro Animal Health Corporation is scheduled to release their next quarterly earnings announcement on Monday, November, 6th 2017. View Earnings Estimates for Phibro Animal Health Corporation.

What guidance has Phibro Animal Health Corporation issued on next quarter's earnings?

Phibro Animal Health Corporation issued an update on its FY18 earnings guidance on Wednesday, August, 30th. The company provided earnings per share (EPS) guidance of $1.55-1.61 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.54. The company issued revenue guidance of $765-790 million, compared to the consensus revenue estimate of $782.65 million.

Where is Phibro Animal Health Corporation's stock going? Where will Phibro Animal Health Corporation's stock price be in 2017?

5 analysts have issued 12 month target prices for Phibro Animal Health Corporation's shares. Their predictions range from $21.00 to $41.00. On average, they anticipate Phibro Animal Health Corporation's stock price to reach $33.00 in the next year. View Analyst Ratings for Phibro Animal Health Corporation.

Who are some of Phibro Animal Health Corporation's key competitors?

Some companies that are related to Phibro Animal Health Corporation include Ligand Pharmaceuticals Incorporated (LGND), Neogen Corporation (NEOG), Portola Pharmaceuticals (PTLA), GW Pharmaceuticals PLC (GWPH), Globus Medical (GMED), Wright Medical Group N.V. (WMGI), Nevro Corp. (NVRO), NuVasive (NUVA), Halozyme Therapeutics (HALO), The Medicines Company (MDCO), Blueprint Medicines Corporation (BPMC), Myriad Genetics (MYGN), Allscripts Healthcare Solutions (MDRX), Select Medical Holdings Corporation (SEM), Amicus Therapeutics (FOLD), Haemonetics Corporation (HAE), DBV Technologies S.A. (DBVT) and Array BioPharma (ARRY).

Who are Phibro Animal Health Corporation's key executives?

Phibro Animal Health Corporation's management team includes the folowing people:

Jack Clifford Bendheim, Chairman of the Board, President, Chief Executive Officer
Richard G. Johnson, Chief Financial Officer
Dean J. Warras, President - Animal Health & Nutrition, North America
Larry Lee Miller, Chief Operating Officer
Daniel M. Bendheim, Executive Vice President, Director, Corporate Strategy
Thomas Golden Dagger, Senior Vice President, General Counsel, Corporate Secretary
Lisa A. Escudero, Senior Vice President-Human Resources
David C. Storbeck, Vice President - Finance, Treasurer
Gerald K. Carlson, Director
E. Thomas Corcoran, Independent Director

How do I buy Phibro Animal Health Corporation stock?

Shares of Phibro Animal Health Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Phibro Animal Health Corporation's stock price today?

One share of Phibro Animal Health Corporation stock can currently be purchased for approximately $37.45.

MarketBeat Community Rating for Phibro Animal Health Corporation (NASDAQ PAHC)

Community Ranking:		2.6 out of 5 ( )
Outperform Votes:		140 (Vote Outperform)
Underperform Votes:		131 (Vote Underperform)
Total Votes:		271

MarketBeat's community ratings are surveys of what our community members think about Phibro Animal Health Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Consensus Ratings for Phibro Animal Health Corporation (NASDAQ:PAHC) (How are Consensus Ratings Calculated?)

Ratings Breakdown:	2 Sell Ratings, 1 Hold Rating, 2 Buy Ratings
Consensus Rating:	Hold (Score: 2.00)
Consensus Price Target:	$33.00 (11.88% downside)

Consensus Price Target History for Phibro Animal Health Corporation (NASDAQ:PAHC)

Analysts' Ratings History for Phibro Animal Health Corporation (NASDAQ:PAHC)

Show:

Date	Firm	Action	Rating	Price Target	Impact on Share Price
10/6/2017	Piper Jaffray Companies	Set Price Target	Buy	$41.00	N/A
8/31/2017	Credit Suisse Group	Boost Price Target	Outperform	$36.00 -> $37.00	High
8/23/2017	Bank of America Corporation	Reiterated Rating	Underperform -> Underperform	$33.00	High
11/11/2016	Macquarie	Downgrade	Neutral -> Underperform	$21.00	N/A
11/10/2016	Gabelli	Downgrade	Buy -> Hold		N/A
9/12/2016	Guggenheim	Set Price Target	Buy	$26.00 -> $30.00	N/A
9/4/2016	Morgan Stanley	Set Price Target	Sell	$23.00	N/A
1/15/2016	Barclays PLC	Downgrade	Overweight -> Underweight	$36.00 -> $31.00	N/A

(Data available from 10/18/2015 forward)

Earnings History for Phibro Animal Health Corporation (NASDAQ:PAHC)

Earnings by Quarter for Phibro Animal Health Corporation (NASDAQ:PAHC)

Earnings History by Quarter for Phibro Animal Health Corporation (NASDAQ PAHC)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
11/6/2017		$0.39					N/A
8/30/2017	Q4 2017	$0.35	$0.39	$192.47 million	$194.84 million	View	N/A
5/8/2017	Q3 2017	$0.37	$0.37	$185.90 million	$190.00 million	View	Listen
2/6/2017	Q217	$0.35	$0.39	$194.16 million	$192.00 million	View	Listen
11/9/2016	Q1 2017	$0.34	$0.36	$188.85 million	$188.00 million	View	Listen
8/29/2016	Q416	$0.38	$0.40		$189.20 million	View	N/A
5/9/2016	Q316	$0.43	$0.38	$197.24 million	$183.00 million	View	N/A
2/9/2016	Q216	$0.41	$0.39	$198.27 million	$191.80 million	View	N/A
11/9/2015	Q1	$0.41	$0.44	$192.28 million	$187.10 million	View	N/A
9/9/2015	Q415	$0.38	$0.44		$185.00 million	View	N/A
5/11/2015	Q315	$0.36	$0.41	$187.80 million	$187.50 million	View	N/A
2/10/2015	Q215	$0.36	$0.35	$181.52 million	$188.70 million	View	N/A
11/11/2014	Q115	$0.35	$0.51	$174.90 million	$187.50 million	View	N/A
9/16/2014	Q414	$0.27	$0.22	$175.90 million	$183.70 million	View	N/A
5/13/2014	Q314	$0.14	$0.21	$162.70 million	$173.30 million	View	N/A

(Data available from 1/1/2011 forward)

Earnings Estimates for Phibro Animal Health Corporation (NASDAQ:PAHC)

Current Year EPS Consensus Estimate: $1.57 EPS
Next Year EPS Consensus Estimate: $1.68 EPS

Current Dividend Information for Phibro Animal Health Corporation (NASDAQ:PAHC)

Most Recent Dividend:	9/27/2017
Annual Dividend:	$0.40
Dividend Yield:	1.07%
Payout Ratio:	24.69% (Trailing 12 Months of Earnings) 25.48% (Based on This Year's Estimates) 23.81% (Based on Next Year's Estimates)

Dividend Payments by Quarter for Phibro Animal Health Corporation (NASDAQ:PAHC)

Dividend History by Quarter for Phibro Animal Health Corporation (NASDAQ PAHC)

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/25/2017	quarterly	$0.10	1.04%	9/1/2017	9/6/2017	9/27/2017
5/9/2017	Quarterly	$0.10	1.2%	5/26/2017	5/31/2017	6/22/2017
2/7/2017	quarterly	$0.10	1.37%	2/27/2017	3/1/2017	3/22/2017
11/8/2016	quarterly	$0.10	1.51%	11/28/2016	11/30/2016	12/21/2016
7/26/2016	quarterly	$0.10	1.95%	9/2/2016	9/7/2016	9/28/2016
5/10/2016	quarterly	$0.10	2.17%	5/27/2016	6/1/2016	6/22/2016
2/9/2016	quarterly	$0.10	1.18%	2/29/2016	3/2/2016	3/23/2016
11/10/2015	quarterly	$0.10	1.26%	11/30/2015	12/2/2015	12/23/2015
7/28/2015	quarterly	$0.10	1.08%	8/31/2015	9/2/2015	9/23/2015
5/12/2015	quarterly	$0.10	1.09%	6/1/2015	6/3/2015	6/24/2015
2/10/2015	quarterly	$0.10	1.43%	3/2/2015	3/4/2015	3/25/2015
11/10/2014	quarterly	$0.10	1.43%	12/1/2014	12/3/2014	12/23/2014
7/28/2014	quarterly	$0.10		8/29/2014	9/3/2014	9/24/2014

(Data available from 1/1/2013 forward)

Insider Trading and Institutional Ownership History for Phibro Animal Health Corporation (NASDAQ:PAHC)

Insider Ownership Percentage: 51.88%
Institutional Ownership Percentage: 48.05%

Institutional Ownership by Quarter for Phibro Animal Health Corporation (NASDAQ:PAHC)

Insider Trades by Quarter for Phibro Animal Health Corporation (NASDAQ:PAHC)

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
9/15/2017	Dean J Warras	Insider	Sell	10,000	$35.70	$357,000.00
9/14/2017	Larry Lee Miller	COO	Sell	21,439	$36.43	$781,022.77
9/14/2017	Richard G Johnson	CFO	Sell	55,529	$36.30	$2,015,702.70
9/13/2017	Larry Lee Miller	COO	Sell	15,891	$36.46	$579,385.86
9/13/2017	Richard G Johnson	CFO	Sell	15,900	$36.46	$579,714.00
9/12/2017	Larry Lee Miller	COO	Sell	46,102	$36.33	$1,674,885.66
9/12/2017	Richard G Johnson	CFO	Sell	47,264	$36.32	$1,716,628.48
9/11/2017	Gerald K Carlson	Director	Sell	5,400	$36.27	$195,858.00
9/7/2017	Larry Lee Miller	COO	Sell	32,459	$35.59	$1,155,215.81
9/7/2017	Richard G Johnson	CFO	Sell	29,807	$35.66	$1,062,917.62
8/21/2017	Daniel M Bendheim	VP	Sell	4,976	$40.01	$199,089.76
8/16/2017	Daniel M Bendheim	VP	Sell	5,938	$40.04	$237,757.52
8/15/2017	Daniel M Bendheim	VP	Sell	1,443	$40.05	$57,792.15
8/14/2017	Daniel M Bendheim	VP	Sell	300	$40.08	$12,024.00
7/6/2017	Bfi Co., Llc	Major Shareholder	Sell	16,000	$36.00	$576,000.00
7/6/2017	Jack Bendheim	Insider	Sell	32,000	$36.49	$1,167,680.00
7/5/2017	Bfi Co., Llc	Major Shareholder	Sell	16,000	$36.98	$591,680.00
6/30/2017	Bfi Co., Llc	Major Shareholder	Sell	48,000	$37.42	$1,796,160.00
6/23/2017	Jack Bendheim	Insider	Sell	48,000	$37.15	$1,783,200.00
6/15/2017	Bfi Co., Llc	Major Shareholder	Sell	48,000	$34.82	$1,671,360.00
6/9/2017	Jack Bendheim	Insider	Sell	48,000	$35.62	$1,709,760.00
5/25/2017	Jack Bendheim	Insider	Sell	48,000	$34.67	$1,664,160.00
5/19/2017	Jack Bendheim	Insider	Sell	48,000	$34.15	$1,639,200.00
5/11/2017	Gerald K Carlson	Director	Sell	63,338	$33.31	$2,109,788.78
5/10/2017	Jack Bendheim	Insider	Sell	1,400	$34.04	$47,656.00
5/9/2017	Larry Lee Miller	COO	Sell	56,825	$30.95	$1,758,733.75
5/9/2017	Thomas G Dagger	SVP	Sell	8,000	$32.13	$257,040.00
5/4/2017	Larry Lee Miller	COO	Sell	18,953	$30.13	$571,053.89
5/1/2017	Larry Lee Miller	COO	Sell	14,780	$30.13	$445,321.40
3/20/2017	Gerald K Carlson	Director	Sell	12,000	$28.13	$337,560.00
2/27/2017	Gerald K Carlson	Director	Sell	12,000	$28.29	$339,480.00
2/16/2017	Daniel A Welch	SVP	Sell	5,000	$29.55	$147,750.00
2/16/2017	Larry Lee Miller	COO	Sell	4,588	$30.00	$137,640.00
2/15/2017	Gerald K Carlson	Director	Sell	12,000	$29.77	$357,240.00
2/13/2017	Larry Lee Miller	COO	Sell	97,229	$30.37	$2,952,844.73
1/4/2017	Thomas G Dagger	SVP	Sell	207	$30.00	$6,210.00
1/3/2017	Larry Lee Miller	COO	Sell	187	$30.00	$5,610.00
12/20/2016	Larry Lee Miller	COO	Sell	1,540	$30.04	$46,261.60
12/20/2016	Thomas G Dagger	SVP	Sell	1,700	$30.03	$51,051.00
12/19/2016	Larry Lee Miller	COO	Sell	252	$30.00	$7,560.00
12/19/2016	Thomas G Dagger	SVP	Sell	200	$30.01	$6,002.00
5/19/2016	E Thomas Corcoran	Director	Buy	5,000	$18.14	$90,700.00
4/1/2016	Gerald K Carlson	COO	Sell	8,000	$27.02	$216,160.00
2/19/2016	Gerald K Carlson	COO	Sell	8,000	$28.09	$224,720.00
2/17/2016	Bfi Co., Llc	Major Shareholder	Sell	2,175	$30.01	$65,271.75
2/10/2016	Bfi Co., Llc	major shareholder	Sell	3,400	$30.78	$104,652.00
2/3/2016	Bfi Co., Llc	major shareholder	Sell	4,000	$33.26	$133,040.00
2/3/2016	Jack Bendheim	CEO	Sell	12,000	$33.39	$400,680.00
2/2/2016	Bfi Co., Llc	major shareholder	Sell	4,000	$33.44	$133,760.00
2/1/2016	Bfi Co., Llc	major shareholder	Sell	4,000	$33.46	$133,840.00
2/1/2016	Larry Lee Miller	President	Sell	60,000	$33.58	$2,014,800.00
1/29/2016	Jack Bendheim	CEO	Sell	39,944	$32.10	$1,282,202.40
1/26/2016	Daniel A. Welch	SVP	Sell	3,000	$32.05	$96,150.00
1/26/2016	Gerald K. Carlson	COO	Sell	12,923	$32.13	$415,215.99
1/22/2016	Larry Lee Miller	President	Sell	51,225	$30.07	$1,540,335.75
1/20/2016	Gerald K. Carlson	COO	Sell	8,000	$29.27	$234,160.00
1/8/2016	Larry Lee Miller	President	Sell	4,303	$30.03	$129,219.09
1/6/2016	Bfi Co., Llc	major shareholder	Sell	3,005	$29.93	$89,939.65
1/6/2016	Jack Bendheim	CEO	Sell	8,056	$30.01	$241,760.56
1/6/2016	Larry Lee Miller	President	Sell	4,472	$30.10	$134,607.20
1/5/2016	Bfi Co., Llc	major shareholder	Sell	4,851	$30.07	$145,869.57
1/4/2016	Bfi Co., Llc	major shareholder	Sell	200	$29.92	$5,984.00
12/30/2015	Bfi Co., Llc	major shareholder	Sell	4,000	$30.63	$122,520.00
12/30/2015	Jack Bendheim	CEO	Sell	12,000	$30.49	$365,880.00
12/29/2015	Bfi Co., Llc	major shareholder	Sell	4,000	$30.49	$121,960.00
12/28/2015	Bfi Co., Llc	major shareholder	Sell	4,000	$30.34	$121,360.00
12/23/2015	Gerald K. Carlson	COO	Sell	2,006	$32.03	$64,252.18
12/22/2015	Gerald K. Carlson	COO	Sell	1,071	$32.02	$34,293.42
12/21/2015	Gerald K. Carlson	COO	Sell	8,000	$31.13	$249,040.00
12/18/2015	Jack Bendheim	CEO	Sell	12,000	$31.83	$381,960.00
12/15/2015	Larry Lee Miller	insider	Sell	36,090	$31.00	$1,118,790.00
12/14/2015	Larry Lee Miller	insider	Sell	23,910	$30.74	$734,993.40
12/11/2015	Jack Bendheim	CEO	Sell	12,000	$31.58	$378,960.00
12/3/2015	Jack Bendheim	CEO	Sell	12,000	$32.63	$391,560.00
11/24/2015	Gerald K. Carlson	COO	Sell	16,000	$32.08	$513,280.00
11/24/2015	Thomas G. Dagger	SVP	Sell	4,000	$32.87	$131,480.00
11/18/2015	Bfi Co., Llc	major shareholder	Sell	4,000	$31.68	$126,720.00
11/18/2015	Jack Bendheim	CEO	Sell	12,000	$31.63	$379,560.00
11/17/2015	Bfi Co., Llc	major shareholder	Sell	4,000	$31.71	$126,840.00
11/16/2015	Bfi Co., Llc	major shareholder	Sell	4,000	$31.50	$126,000.00
11/12/2015	Bfi Co., Llc	major shareholder	Sell	12,000	$32.21	$386,520.00
11/5/2015	Jack Bendheim	CEO	Sell	12,000	$33.11	$397,320.00
10/30/2015	Jack Bendheim	CEO	Sell	12,000	$33.21	$398,520.00
10/26/2015	Gerald K. Carlson	COO	Sell	7,900	$32.15	$253,985.00
10/26/2015	Jack Bendheim	CEO	Sell	12,000	$31.73	$380,760.00
10/21/2015	Gerald K. Carlson	COO	Sell	8,100	$32.40	$262,440.00
10/16/2015	Daniel A. Welch	SVP	Sell	3,000	$32.93	$98,790.00
10/16/2015	Jack Bendheim	CEO	Sell	12,000	$32.10	$385,200.00
10/9/2015	Jack Bendheim	CEO	Sell	12,000	$30.64	$367,680.00
10/1/2015	Jack Bendheim	CEO	Sell	12,000	$31.44	$377,280.00
9/25/2015	Jack Bendheim	CEO	Sell	10,000	$33.95	$339,500.00
9/23/2015	Thomas G. Dagger	SVP	Sell	4,000	$34.76	$139,040.00
9/22/2015	Gerald K. Carlson	COO	Sell	8,000	$34.97	$279,760.00
9/21/2015	Gerald K. Carlson	COO	Sell	8,000	$35.99	$287,920.00
9/18/2015	Jack Bendheim	CEO	Sell	18,000	$35.90	$646,200.00
9/16/2015	Dean J. Warras	insider	Sell	4,000	$34.73	$138,920.00
9/10/2015	Jack Bendheim	CEO	Sell	18,000	$34.69	$624,420.00
9/3/2015	Bfi Co., Llc	major shareholder	Sell	16,900	$35.08	$592,852.00
9/3/2015	Jack Bendheim	CEO	Sell	1,100	$35.10	$38,610.00
8/28/2015	Jack Bendheim	CEO	Sell	18,000	$34.89	$628,020.00
8/21/2015	Gerald K. Carlson	COO	Sell	16,000	$35.04	$560,640.00
8/19/2015	Bfi Co., Llc	Major Shareholder	Sell	6,000	$36.91	$221,460.00
8/19/2015	Jack Bendheim	CEO	Sell	18,000	$37.14	$668,520.00
8/18/2015	Bfi Co., Llc	Major Shareholder	Sell	6,000	$37.76	$226,560.00
8/17/2015	Bfi Co., Llc	Major Shareholder	Sell	6,000	$36.76	$220,560.00
7/24/2015	Jack Bendheim	CEO	Sell	18,000	$37.98	$683,640.00
7/21/2015	Gerald K Carlson	COO	Sell	8,000	$37.97	$303,760.00
7/20/2015	Gerald K Carlson	COO	Sell	8,000	$38.16	$305,280.00
7/15/2015	Bfi Co., Llc	Major Shareholder	Sell	18,000	$38.13	$686,340.00
7/15/2015	Jack Bendheim	CEO	Sell	6,000	$37.75	$226,500.00
7/14/2015	Jack Bendheim	CEO	Sell	6,000	$38.25	$229,500.00
7/13/2015	Jack Bendheim	CEO	Sell	6,000	$38.41	$230,460.00
7/9/2015	Jack Bendheim	CEO	Sell	18,000	$36.90	$664,200.00
7/2/2015	Bfi Co., Llc	Major Shareholder	Sell	19,000	$38.02	$722,380.00
6/26/2015	Jack Bendheim	CEO	Sell	36,000	$36.37	$1,309,320.00
6/23/2015	Gerald K Carlson	COO	Sell	16,000	$36.56	$584,960.00
6/22/2015	Gerald K Carlson	COO	Sell	8,000	$36.47	$291,760.00
6/17/2015	Bfi Co., Llc	Major Shareholder	Sell	4,000	$34.09	$136,360.00
6/17/2015	Jack Bendheim	CEO	Sell	12,000	$33.13	$397,560.00
6/16/2015	Bfi Co., Llc	Major Shareholder	Sell	4,000	$33.00	$132,000.00
6/15/2015	Bfi Co., Llc	Major Shareholder	Sell	4,000	$32.31	$129,240.00
6/11/2015	Jack Bendheim	CEO	Sell	12,000	$32.38	$388,560.00
6/4/2015	Jack Bendheim	CEO	Sell	12,000	$33.68	$404,160.00
5/28/2015	Bfi Co., Llc	Major Shareholder	Sell	18,000	$35.11	$631,980.00
5/21/2015	Gerald K Carlson	COO	Sell	16,000	$35.62	$569,920.00
5/19/2015	Bfi Co., Llc	Major Shareholder	Sell	18,000	$36.73	$661,140.00
5/18/2015	Thomas G Dagger	SVP	Sell	4,000	$36.48	$145,920.00
12/19/2014	Daniel A Welch	SVP	Sell	4,000	$29.20	$116,800.00
8/1/2014	Bfi Co., Llc	Major Shareholder	Sell	223,075	$20.51	$4,575,268.25
4/22/2014	E Thomas Corcoran	Director	Buy	5,000	$16.70	$83,500.00
4/16/2014	Carol Wrenn	Director	Buy	1,000	$16.19	$16,190.00
4/16/2014	L.P. Mayflower	Major Shareholder	Sell	6,323,867	$13.99	$88,470,899.33

(Data available from 1/1/2013 forward)

Headline Trends for Phibro Animal Health Corporation (NASDAQ:PAHC) Latest Headlines for Phibro Animal Health Corporation (NASDAQ:PAHC)

Source:

Date	Headline
	Phibro Animal Health Corp. breached its 50 day moving average in a Bullish Manner : PAHC-US : October 17, 2017 finance.yahoo.com - October 17 at 8:51 PM
	Phibro Animal Health Corporation to Participate in the Credit Suisse Healthcare Conference finance.yahoo.com - October 17 at 6:07 AM
	Phibro Animal Health Corporation (PAHC) Given a $41.00 Price Target at Piper Jaffray Companies www.americanbankingnews.com - October 7 at 7:36 AM
	Phibro Animal Health Corp. breached its 50 day moving average in a Bullish Manner : PAHC-US : October 5, 2017 finance.yahoo.com - October 5 at 2:52 PM
	Phibro Animal Health Corporation to Host Webcast and Conference Call on September 2017 Quarterly Financial Results feeds.benzinga.com - October 3 at 4:59 PM
	Phibro Animal Health Corporation (PAHC) Receives Average Rating of "Hold" from Analysts www.americanbankingnews.com - September 24 at 12:42 AM
	Earnings Review and Free Research Report: Phibro Animal Health’s Net Sales Grew 3%; Adjusted EPS Surged 22% finance.yahoo.com - September 22 at 8:08 AM
	Phibro Animal Health Corporation (PAHC) Insider Sells $357,000.00 in Stock www.americanbankingnews.com - September 20 at 10:22 PM
	Phibro Animal Health Corporation (PAHC) COO Sells $579,385.86 in Stock www.americanbankingnews.com - September 15 at 10:46 PM
	Phibro Animal Health Corporation (PAHC) COO Sells $781,022.77 in Stock www.americanbankingnews.com - September 15 at 10:46 PM
	Richard G. Johnson Sells 15,900 Shares of Phibro Animal Health Corporation (PAHC) Stock www.americanbankingnews.com - September 15 at 10:46 PM
	Insider Selling: Phibro Animal Health Corporation (PAHC) CFO Sells 55,529 Shares of Stock www.americanbankingnews.com - September 15 at 10:46 PM
	Phibro Animal Health Corp. :PAHC-US: Earnings Analysis: Q4, 2017 By the Numbers : September 12, 2017 finance.yahoo.com - September 13 at 7:35 AM
	Phibro Animal Health Corporation (PAHC) Director Sells $195,858.00 in Stock www.americanbankingnews.com - September 12 at 10:16 PM
	Phibro Animal Health Corporation (PAHC) COO Sells $1,674,885.66 in Stock www.americanbankingnews.com - September 12 at 10:16 PM
	Phibro Animal Health Corporation (PAHC) CFO Richard G. Johnson Sells 47,264 Shares www.americanbankingnews.com - September 12 at 10:16 PM
	Insider Selling: Phibro Animal Health Corporation (PAHC) CFO Sells 29,807 Shares of Stock www.americanbankingnews.com - September 8 at 1:22 PM
	ETFs with exposure to Phibro Animal Health Corp. : September 7, 2017 finance.yahoo.com - September 8 at 6:56 AM
	Insider Selling: Phibro Animal Health Corporation (PAHC) COO Sells 32,459 Shares of Stock www.americanbankingnews.com - September 7 at 10:22 PM
	Phibro Animal Health Corp. :PAHC-US: Earnings Analysis: 2017 By the Numbers : September 6, 2017 finance.yahoo.com - September 7 at 7:23 AM
	Gabelli Comments on Phibro Animal Health Corporation's FY2019 Earnings (PAHC) www.americanbankingnews.com - September 4 at 8:32 AM
	Phibro Animal Health's (PAHC) CEO Jack Bendheim on Q4 2017 Results - Earnings Call Transcript seekingalpha.com - September 2 at 7:19 AM
	Phibro Animal Health Corp. (PAHC) PT Lowered to $41 at Piper Jaffray; Reiterates Overweight www.streetinsider.com - September 2 at 7:19 AM
	Piper Jaffray Companies Reiterates "Buy" Rating for Phibro Animal Health Corporation (PAHC) www.americanbankingnews.com - September 1 at 2:16 PM
	Edited Transcript of PAHC earnings conference call or presentation 31-Aug-17 1:00pm GMT finance.yahoo.com - September 1 at 6:57 AM
	Credit Suisse Group Boosts Phibro Animal Health Corporation (PAHC) Price Target to $37.00 www.americanbankingnews.com - August 31 at 5:02 PM
	Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year finance.yahoo.com - August 31 at 8:27 AM
	Phibro Animal Health Corp. – Value Analysis (NASDAQ:PAHC) : August 30, 2017 finance.yahoo.com - August 31 at 8:27 AM
	Phibro beats 4Q profit forecasts finance.yahoo.com - August 31 at 8:27 AM
	Investor Network: Phibro Animal Health Corporation Class A to Host Earnings Call finance.yahoo.com - August 31 at 8:27 AM
	Phibro Animal Health Corporation (PAHC) Posts Quarterly Earnings Results, Beats Estimates By $0.05 EPS www.americanbankingnews.com - August 30 at 5:58 PM
	Phibro Animal Health Corporation (PAHC) Releases FY18 Earnings Guidance www.americanbankingnews.com - August 30 at 5:38 PM
	Phibro Animal Health Corporation (PAHC) Given Average Recommendation of "Hold" by Analysts www.americanbankingnews.com - August 30 at 12:44 AM
	Phibro Animal Health Corporation (PAHC) PT Set at $42.00 by Piper Jaffray Companies www.americanbankingnews.com - August 26 at 11:22 AM
	Phibro Animal Health Corp. breached its 50 day moving average in a Bearish Manner : PAHC-US : August 24, 2017 finance.yahoo.com - August 24 at 10:46 AM
	Phibro Animal Health Corporation (PAHC) Coverage Initiated by Analysts at Bank of America Corporation www.americanbankingnews.com - August 23 at 9:30 AM
	Phibro Animal Health Corporation (PAHC) Set to Announce Earnings on Wednesday www.americanbankingnews.com - August 23 at 1:32 AM
	Insider Selling: Phibro Animal Health Corporation (PAHC) VP Sells 4,976 Shares of Stock www.americanbankingnews.com - August 22 at 1:32 PM
	Phibro Animal Health Corporation (PAHC) VP Daniel M. Bendheim Sells 300 Shares www.americanbankingnews.com - August 16 at 10:44 PM
	Daniel M. Bendheim Sells 1,443 Shares of Phibro Animal Health Corporation (PAHC) Stock www.americanbankingnews.com - August 16 at 10:44 PM
	Insider Selling: Phibro Animal Health Corporation (PAHC) VP Sells 5,938 Shares of Stock www.americanbankingnews.com - August 16 at 10:44 PM
	See what the IHS Markit Score report has to say about Phibro Animal Health Corp. finance.yahoo.com - August 10 at 6:40 AM
	Phibro Animal Health Corporation to Participate in the Morgan Stanley 2017 Global Healthcare Conference feeds.benzinga.com - August 9 at 7:21 PM
	Phibro Animal Health Corporation (PAHC) Receives Consensus Rating of "Hold" from Brokerages www.americanbankingnews.com - August 5 at 12:38 AM
	Phibro Animal Health Corporation (NASDAQ:PAHC) Declares $0.10 Quarterly Dividend www.americanbankingnews.com - July 25 at 4:47 PM
	Brokerages Expect Phibro Animal Health Corporation (PAHC) to Announce $0.36 EPS www.americanbankingnews.com - July 21 at 10:18 PM
	Phibro Animal Health Corporation (NASDAQ:PAHC) Stock Rating Reaffirmed by Piper Jaffray Companies www.americanbankingnews.com - July 21 at 9:14 PM
	Analyzing Phibro Animal Health Corporation (NASDAQ:PAHC) & Zoetis (ZTS) www.americanbankingnews.com - July 12 at 8:18 AM
	Phibro Animal Health Corporation (PAHC) Receives Consensus Recommendation of "Hold" from Analysts www.americanbankingnews.com - July 11 at 12:20 AM
	Insider Selling: Phibro Animal Health Corporation (PAHC) Major Shareholder Sells 16,000 Shares of Stock www.americanbankingnews.com - July 7 at 10:43 PM